{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:06:13Z","timestamp":1791288373155,"version":"4.3.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12282-016-0697-0","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T15:11:46Z","timestamp":1461078706000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A unique hypofractionated radiotherapy schedule with 51.3\u00a0Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity"],"prefix":"10.1007","volume":"24","author":[{"given":"Kouloulias","family":"Vassilis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gogalis","family":"Ioannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygogianni","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armpilia","family":"Christina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antypas","family":"Christos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kokakis","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koromperlis","family":"Porfyrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennimata","family":"Vassiliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouvaris","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"697_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0360-3016(85)90366-9","volume":"11","author":"MV Williams","year":"1985","unstructured":"Williams MV, Denekamp J, Fowler JF. A review of alpha\/beta ratios for experimental tumours: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985;11:87\u201396.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"697_CR2","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2004.05.072","volume":"60","author":"BS Rosenstein","year":"2004","unstructured":"Rosenstein BS, Lymberis SC, Formenti SC. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys. 2004;60:1394\u2013404.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"697_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2005.03.017","volume":"75","author":"JM Kurtz","year":"2005","unstructured":"Kurtz JM. The clinical radiobiology of breast cancer radiotherapy. Radiother Oncol. 2005;75:6\u20138.","journal-title":"Radiother Oncol"},{"key":"697_CR4","first-page":"71","volume":"13","author":"B Jones","year":"2001","unstructured":"Jones B, Dale RG, Deehan K, Hopkins KI, Morgan DAL. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol. 2001;13:71\u201381.","journal-title":"Clin Oncol"},{"key":"697_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0360-3016(98)00507-0","volume":"44","author":"Y Yamada","year":"1999","unstructured":"Yamada Y, Ackerman I, Franssen E, MacKenzie RG, Thomas G. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys. 1999;44:99\u2013104.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"697_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","volume":"75","author":"J Yarnold","year":"2005","unstructured":"Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomized trial. Radiother Oncol. 2005;75:9\u201317.","journal-title":"Radiother Oncol"},{"key":"697_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","volume":"7","author":"JR Owen","year":"2006","unstructured":"Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomize trial. Lancet Oncol. 2006;7:467\u201371.","journal-title":"Lancet Oncol"},{"key":"697_CR8","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/jnci\/88.22.1659","volume":"88","author":"RM Clark","year":"1996","unstructured":"Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumphectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88:1659\u201364.","journal-title":"J Natl Cancer Inst"},{"key":"697_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-8140(96)91824-1","volume":"41","author":"IA Olivotto","year":"1996","unstructured":"Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996;41:7\u201313.","journal-title":"Radiother Oncol"},{"key":"697_CR10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(00)00567-8","volume":"47","author":"W Shelley","year":"2000","unstructured":"Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for post lumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;47:1219\u201328.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"697_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12282-007-0010-3","volume":"15","author":"O Fujii","year":"2008","unstructured":"Fujii O, Hiratsuka J, Nagase N, et al. Whole breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes. Breast Cancer. 2008;15:86\u201392.","journal-title":"Breast Cancer"},{"key":"697_CR12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clon.2006.11.006","volume":"19","author":"L Livi","year":"2007","unstructured":"Livi L, Stefanacci M, Scoccianti S, et al. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. R Coll Radiol. 2007;19:120\u20134.","journal-title":"R Coll Radiol"},{"key":"697_CR13","first-page":"58","volume":"16","author":"AG Zygogianni","year":"2011","unstructured":"Zygogianni AG, Kouloulias V, Armpilia C, Balafouta M, Antypas C, Kouvaris JR. The potential role of hypofractionated accelerated radiotherapy to cosmesis for stage I-II breast carcinoma: a prospective study. J BUON. 2011;16:58\u201363.","journal-title":"J BUON"},{"key":"697_CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1524-4741.2010.00913.x","volume":"16","author":"AG Zygogianni","year":"2010","unstructured":"Zygogianni AG, Kouvaris JR, Kouloulias V, Armpilia C, Antypas C, Vlachos L. Hypofractionated accelerated irradiation for stage I-II breast carcinoma: a phase II study. Breast J. 2010;16:337\u20138.","journal-title":"Breast J"},{"key":"697_CR15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","volume":"94","author":"T Whelan","year":"2002","unstructured":"Whelan T, MacKenziew R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143\u201350.","journal-title":"J Natl Cancer Inst"},{"key":"697_CR16","first-page":"S30","volume":"16","author":"J Yarnold","year":"2004","unstructured":"Yarnold J, Bloomeld D, LeVay J. Prospective randomized trial testing 5.7\u00a0Gy and 6.0\u00a0Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol. 2004;16:S30.","journal-title":"Clin Oncol"},{"key":"697_CR17","first-page":"1098","volume":"29","author":"The START \u2018Trialists\u2019 Group.","year":"2008","unstructured":"The START \u2018Trialists\u2019 Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008;29:1098\u2013107.","journal-title":"Lancet"},{"key":"697_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","volume":"9","author":"The START \u2018Trialists\u2019 Group","year":"2008","unstructured":"The START \u2018Trialists\u2019 Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008;9:331\u201341.","journal-title":"Lancet"},{"key":"697_CR19","first-page":"3","volume-title":"Prescribing, recording and reporting photon beam therapy, ICRU report 50","author":"International Commission on Radiation Units and Measurements","year":"1993","unstructured":"International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy, ICRU report 50. Bethesda: International Commission on Radiation Units and Measurements; 1993. p. 3\u201316."},{"key":"697_CR20","volume-title":"Prescribing, recording and reporting photon beam therapy, ICRU report 62","author":"International Commission on Radiation Units and Measurements","year":"1999","unstructured":"International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy, ICRU report 62. Bethesda: International Commission on Radiation Units and Measurements; 1999."},{"key":"697_CR21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1259\/bjr\/94471640","volume":"81","author":"M Wyatt","year":"2008","unstructured":"Wyatt M, Jones BJ, Dale RG. Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules. Br J Radiol. 2008;81:549\u201363.","journal-title":"Br J Radiol"},{"key":"697_CR22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1524-4741.2009.00865.x","volume":"16","author":"SD Ramsey","year":"2010","unstructured":"Ramsey SD, Zeliadt SB, Richardson LC. Discontinuation of radiation treatment among Medicaid-enrolled women with local and regional stage breast cancer. Breast J. 2010;16:20\u20137.","journal-title":"Breast J"},{"key":"697_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-011-1932-1","volume":"134","author":"P Sanpaolo","year":"2012","unstructured":"Sanpaolo P, Barbieri P, Genovesi D, Fusco V, Cefaro GA. Biologically effective dose and breast cancer conservative treatment: is duration of radiation therapy really important? Breast Cancer Res Treat. 2012;134:81\u20137.","journal-title":"Breast Cancer Res Treat"},{"key":"697_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2011.01.010","volume":"100","author":"XS Qi","year":"2011","unstructured":"Qi XS, White J, Li XA. Is \u03b1\/\u03b2 for breast cancer really low? Radiother Oncol. 2011;100:282\u20138.","journal-title":"Radiother Oncol"},{"key":"697_CR25","doi-asserted-by":"publisher","first-page":"713420","DOI":"10.1155\/2013\/713420","volume":"2013","author":"Z Thrapsanioti","year":"2013","unstructured":"Thrapsanioti Z, Karanasiou I, Platoni K, et al. Transformation of physical DVHs to radiobiologically equivalent ones in hypofractionated radiotherapy analyzing dosimetric and clinical parameters: a practical approach for routine clinical practice in radiation oncology. Comput Math Methods Med. 2013;2013:713420. doi: 10.1155\/2013\/713420 .","journal-title":"Comput Math Methods Med."},{"issue":"3","key":"697_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"S Bentzen","year":"2010","unstructured":"Bentzen S, Constine L, Deasy J, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues. Int J Radiat Oncol Biol Phys. 2010;76(3):3\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"697_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-8140(97)00164-3","volume":"46","author":"K Haustermans","year":"1998","unstructured":"Haustermans K, Fowler J, Geboes K, et al. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: is it worthwhile to measure Tpot? Radiother Oncol. 1998;46:157\u201367.","journal-title":"Radiother Oncol"},{"key":"697_CR28","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, et al. Viewpoint: local Recurrence and 15\u00a0Year Survival in Early Breast Cancer: An Important Meta-analysis. Lancet. 2005;366:2087\u2013106.","journal-title":"Lancet"},{"key":"697_CR29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(00)02263-7","volume":"355","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2000","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. (EBCTCG). Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet. 2000;355:1757\u201370.","journal-title":"Lancet"},{"key":"697_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S1460396910000294","volume":"10","author":"C Armpilia","year":"2011","unstructured":"Armpilia C, Antypas C, Zygogianni A, et al. A review on radiotherapy hypofractionated schedules for breast cancer treatment. J Radiother pract. 2011;10:201\u20138.","journal-title":"J Radiother pract"},{"key":"697_CR31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol J-P, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320.","journal-title":"N Engl J Med"},{"issue":"11","key":"697_CR32","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10\u00a0year follow-up results of two 17 randomized controlled trials. Lancet Oncol. 2013;14(11):1086\u201394.","journal-title":"Lancet Oncol"},{"issue":"1","key":"697_CR33","first-page":"93e100","volume":"100","author":"RK Agrawal","year":"2011","unstructured":"Agrawal RK, Alhasso A, Barrett-Lee PJ, et al. First results of the 17randomized UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015). Radiother Oncol. 2011;100(1):93e100.","journal-title":"Radiother Oncol"},{"issue":"2","key":"697_CR34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clon.2012.10.013","volume":"25","author":"CE Coles","year":"2013","unstructured":"Coles CE, Brunt AM, Wheatley D, Mukesh MB, Yarnold JR. Breast radiotherapy: less is more? Clin Oncol. 2013;25(2):127\u201334.","journal-title":"Clin Oncol"},{"issue":"1","key":"697_CR35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2008.11.005","volume":"75","author":"YM Kirova","year":"2009","unstructured":"Kirova YM, Campana F, Savignoni A, et al. Institut Curie Breast Cancer Study Group. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2009;75(1):76\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"697_CR36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0959-8049(02)00461-6","volume":"39","author":"VE Kouloulias","year":"2003","unstructured":"Kouloulias VE. Quality assurance in radiotherapy. Eur J Cancer. 2003;39(4):415\u201322.","journal-title":"Eur J Cancer"},{"issue":"3","key":"697_CR37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","volume":"82","author":"E Donovan","year":"2007","unstructured":"Donovan E, Bleakley N, Denholm E, et al. Breast Technology Group. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007;82(3):254\u201364.","journal-title":"Radiother Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-016-0697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-016-0697-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-016-0697-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-016-0697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:41:01Z","timestamp":1559580061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-016-0697-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1007\/s12282-016-0697-0","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}